- Global Pharma News & Resources

Cytomegalovirus Treatment Market Set to Witness an Uptick Size USD 326 Million By 2028: Future Market Insights, Inc.

The cytomegalovirus treatment market growth currently stands at US$ 228.8 Mn in 2022. Rising at a CAGR of 6.1% (2022-2028), demand for cytomegalovirus treatment is predicted to reach a market valuation of US$ 326 Mn by the end of 2028

The number of people with CMV is steadily increasing, prompting the introduction of efficient treatment plans and medicines. According to information provided by MedlinePlus, by the time they are 40, between 50 and 80 percent of persons in the US have had CMV symptoms.

According to these statistics, the use of CMV treatment products and techniques will increase in the future, providing producers with ongoing potential to generate sizable profits.

Hospital Pharmacies Remain Highly Lucrative Channel for Manufacturers with Notable ROI Benefits

As per the report, congenital CMV infection registers substantial demand for cytomegalovirus treatment, with global sales expected to surpass over US$ 65.5 Mn in 2019. Hospital pharmacies are likely to steer sales of cytomegalovirus treatment products and procedures, owing to reliable offerings at reasonable costs.

E-commerce is a fast expanding distribution avenue for manufacturers to market their products because well-informed, contemporary patients want a combination of efficiency and ease.

According to the analysis, the high cost of CMV treatment techniques continues to be a major barrier to adoption and to the market’s potential for growth. The accompanying negative effects of CMV treatment products and procedures are eroding end-user confidence in addition to their expensive prices.

Neutropenia, nausea, thrombocytopenia, haematological toxicity, renal failure, and others are some of the often occurring side effects connected with CMV therapy products and techniques.

Manufacturers in the market for CMV therapy are concentrating on cutting-edge research, leading to improved products with improved features. The market participants are also emphasising the availability of products in various size dimensions to promote consumer convenience.

A number of strategic alliances, purchases, and mergers are taking place in the cytomegalovirus treatment business, allowing the manufacturing firms to combine their production know-how to create competitive products. To broaden its exclusive line of science-based dermocosmetic beauty products, Johnson & Johnson, for instance, completed the acquisition of Ci:z Holdings Co., Ltd. in 2019.

Download Sample Copy @

Key Segments of Cytomegalovirus Treatment Industry Survey

Cytomegalovirus Treatment Market by Drug Type:

  • Valganciclovir for Cytomegalovirus Treatment
  • Ganciclovir for Cytomegalovirus Treatment
  • Cidofovir for Cytomegalovirus Treatment
  • Foscarnet for Cytomegalovirus Treatment
  • Others

Cytomegalovirus Treatment Market by Application:

  • Stem Cell Transplantations
  • Organ Transplantations
  • Congenital CMV Infections
  • Others

Cytomegalovirus Treatment Market by Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • e-Commerce

Get In Touch With Our Team For 20% Flat Discount @

Cytomegalovirus Treatment Market by Region:

  • North America Cytomegalovirus Treatment Market
  • Latin America Cytomegalovirus Treatment Market
  • Europe Cytomegalovirus Treatment Market
  • East Asia Cytomegalovirus Treatment Market
  • South Asia & Pacific Cytomegalovirus Treatment Market
  • Middle East & Africa (MEA) Cytomegalovirus Treatment Market

Top Related Reports Healthcare Market Insights

About Future Market Insights (FMI) 

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.


Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries:
Browse All Reports:

Editor Details

Last Updated: 23-Sep-2022